Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
CNS myelin structural modification induced in vitro by phospholipases A2.
The relationship between the rate of brain volume loss during first 24 months and disability progression over 24 and 48 months in relapsing MS.
[Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis].
Relationship Between Regional Atherosclerosis and Adjacent Spinal Cord Histology.
Hypothalamic abnormality in patients with inflammatory demyelinating disorders.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Clinical and epidemiological profiles of non-traumatic myelopathies.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Nerve ultrasound protocol in differentiating chronic immune-mediated neuropathies.
Cell death of spinal cord ED1(+) cells in a rat model of multiple sclerosis.
Cost-Effectiveness of New Therapies for Multiple Sclerosis In Spain.
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
Susceptibility variants in the CD58 gene locus point to a role of microRNA-548ac in the pathogenesis of multiple sclerosis.
Autoantibodies to tetraspanins (CD9, CD81 and CD82) in demyelinating diseases.
Regulation of oligodendrocyte precursor maintenance by chondroitin sulphate glycosaminoglycans.
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.
Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms).
New Perspectives in Pediatric Neurology-Multiple Sclerosis.
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
Extracellular Vesicles and a Novel Form of Communication in the Brain.
A Predictive Model for Corticosteroid Response in Individual Patients with MS Relapses.
Survey of Neurologist's Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure.
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study.
Perioperative management of a patient undergoing a novel mini-invasive percutaneous transcatheter left ventricular reconstruction procedure.
Pages
« first
‹ previous
…
716
717
718
719
720
721
722
723
724
…
next ›
last »